Development of a method for control of radiopharmaceuticals

Abstract

The aim of the study is to draw up a method for monitoring the isotopic composition of medical solutions of radium-223. The possibility of using gamma spectrometry for control of radium-223, its decay products, and its parent isotopes are considered in the work. Gamma-spectrometric analysis of four samples based on radium-223 was performed